Skip to main content
. 2021 Dec 6;13(12):2100. doi: 10.3390/pharmaceutics13122100

Table 1.

Scaffolds prototypes for DKT controlled release.

Composition (w/v %) F1 F2 F3
DKT 0.44 0.44 0.44
Chitosan 4 4 4
PVA - 2 -
Gelatin - - 4
Citric acid 5 5 5
Benzoic acid 0.2 0.2 0.2
Distilled water q.s 25.0 mL q.s 25.0 mL q.s 25.0 mL

DKT: Dexketoprofen trometamol, PVA: Polyvinyl alcohol, F1: Formulation 1, F2: Formulation 2, F3: Formulation 3.